Back to results
US 11,633,472 B2Granted
Compositions
AssigneeGlaxosmithkline Biologicals SA
InventorsHerve Gressard, Pierre Sae Houer, Laurent Strodiot
Life of this patent
Estimating the term…
Abstract
The disclosure defined by this invention is an immunogenic composition comprising a viral antigen, a sugar and/or polyol, an adipate buffer, calcium ions and/or magnesium ions, and one or more positively charged amino acids.
Claims11
A thermostable liquid immunogenic composition comprising:
- a human live attenuated rotavirus,
- sucrose,
- adipic acid,
- calcium ions,
- histidine, and
- vitamin E succinate (VES);
- wherein said immunogenic composition is in the form of liquid formulations;
- wherein said composition has a level of thermostability such that, after storage of the composition for 2.5 months at 37° C., the composition has a maximum virus titer loss of 1.5, as expressed in log10 ffu/mL as compared to the composition's initial virus titer before storage;
- wherein
- rotavirus is present at an initial titer ranging from 1×105 to 1×108 pfu/mL;
- the concentration of sucrose is 10% w/v;
- the adipic acid is present at a concentration of 6.7% w/v;
- the calcium ions are present at a concentration from 5 mM;
- the VES is present at a concentration of no more than 1.5 mM;
- the histidine is present at a concentration of 0.2%;
- the arginine is present at a concentration of 0.2% w/v.
13 more elements
Dependencies are inferred from the claim text.